Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05862168
Protocol Section: NCT05862168
Start Identification Module Data
Brief Title: Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma A Single-arm Prospective Phase II Trial
Official Title: Neoadjuvant Tislelizumab Combined With Albumin-paclitaxel Cisplatin and Fluorouracil in Patients With Locally Advanced Oral Squamous Cell Carcinoma A Single-arm ProspectivePhase II Study
Acronym: None
Organization: Zhejiang University
Organization Class: OTHER
Organization Study ID: Neo-TIME
Start Status Module Data
Status Verified Date: 2023-07
Overall Status: RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Weijia Fang MD
Lead Sponsor Class: OTHER
Lead Sponsor: Weijia Fang MD
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload